Asparaginase

3 trials 2 recruiting LOncology

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

2 Recruiting

1 Completed trials

3 Sponsors

22 Countries

Phase III

Phase II/III

Phase III: 2 Phase II/III: 1

Oversight events:

1 serious breach 17 temporary halts 2 urgent safety measures 2 corrective measures across 2 trials

View oversight register →

Sponsors using this IMP

Amgen Inc. 1 Medical University Of Lodz 1 Princess Maxima Center For Pediatric Oncology 1

All trials

3 total

Treatment of infants under one year with acute lymphoblastic leukemia according to the Interfant-21 protocol Recruiting

2022-502503-30-00 Phase III 19 countries Princess Maxima Center For Pediatric Oncology
Single-arm interventional study with ruxolitinib and AIEOP-BFM 2017 Poland or AIEOP-BFM 2017 standard of care chemotherapy in children with … Recruiting

2024-518316-39-00 Phase II/III 1 country Medical University Of Lodz
A Randomized Study Comparing Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care Chemotherapy for Older Adults … Ended

2023-503640-14-00 Phase III 17 countries Amgen Inc.

Showing 1–3 of 3 trials

← All drugs A–Z